In-hospital complications are more common among women who undergo LAAO than men. However, according to a new study in JACC: Cardiovascular Interventions, men and women have similar long-term outcomes.

Nirmatrelvir-ritonavir, sold by Pfizer under the name Paxlovid, is commonly prescribed to treat COVID-19. When treating some heart patients, however, physicians may want to consider an alternative approach.

“This systemic failure is a global tragedy, as many premature deaths from CVD could be avoided,” one cardiologist said. 

FFR-guided PCI was associated with improved resource utilization and less radiation exposure, among other benefits, when compared to angiography-guided procedures.

The company plans to integrate the newly acquired microcatheters into its existing robotics platforms. 

Could wearables help AFib patients take fewer blood-thinning medications and reduce their risk of stroke? The team behind a new seven-year analysis hopes to find out. 

Researchers have shared an updated analysis of the SMART-CHOICE study, focusing on major adverse cardiac and cerebrovascular events—as well as bleeding events—among PCI patients after three years. 

“Our ultimate goal is to prevent strokes," one Mayo Clinic electrophysiologist said. "I believe the current study has brought us one step closer.”